What is Zacks Research's Estimate for Docusign Q2 Earnings?

Docusign Inc. (NASDAQ:DOCU - Free Report) - Equities research analysts at Zacks Research reduced their Q2 2027 earnings per share estimates for Docusign in a report issued on Thursday, June 26th. Zacks Research analyst R. Department now forecasts that the company will earn $0.24 per share for the quarter, down from their prior estimate of $0.28. The consensus estimate for Docusign's current full-year earnings is $1.17 per share.

Several other equities research analysts have also weighed in on DOCU. Morgan Stanley cut their target price on shares of Docusign from $92.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, June 6th. William Blair reaffirmed an "outperform" rating on shares of Docusign in a research note on Monday, April 21st. Citigroup reduced their target price on Docusign from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Monday, June 9th. Needham & Company LLC restated a "hold" rating on shares of Docusign in a report on Friday, June 6th. Finally, Jefferies Financial Group cut their price objective on Docusign from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, March 31st. Twelve investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, Docusign has a consensus rating of "Hold" and a consensus target price of $89.77.

Docusign Stock Up 2.4%

NASDAQ DOCU traded up $1.82 during trading on Monday, reaching $78.97. 1,921,092 shares of the stock traded hands, compared to its average volume of 2,857,764. Docusign has a fifty-two week low of $48.80 and a fifty-two week high of $107.86. The firm has a market cap of $15.96 billion, a price-to-earnings ratio of 14.93, a price-to-earnings-growth ratio of 28.87 and a beta of 1.08. The stock's 50-day moving average price is $82.33 and its 200 day moving average price is $84.82.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, June 5th. The company reported $0.90 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.09. The company had revenue of $763.65 million during the quarter, compared to analysts' expectations of $748.79 million. Docusign had a return on equity of 14.27% and a net margin of 36.50%. Docusign's revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.82 EPS.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Hemington Wealth Management grew its stake in shares of Docusign by 318.1% in the first quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after buying an additional 264 shares in the last quarter. Banque Transatlantique SA bought a new position in shares of Docusign in the 1st quarter valued at about $26,000. Golden State Wealth Management LLC grew its position in shares of Docusign by 519.4% in the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after acquiring an additional 322 shares during the period. Summit Securities Group LLC acquired a new position in shares of Docusign during the 1st quarter worth about $34,000. Finally, Wood Tarver Financial Group LLC bought a new stake in shares of Docusign in the 4th quarter valued at about $37,000. Institutional investors and hedge funds own 77.64% of the company's stock.

Insider Activity

In other news, CFO Blake Jeffrey Grayson sold 15,143 shares of the firm's stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $74.80, for a total value of $1,132,696.40. Following the completion of the transaction, the chief financial officer owned 110,723 shares in the company, valued at $8,282,080.40. This trade represents a 12.03% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Robert Chatwani sold 22,875 shares of Docusign stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total value of $1,710,821.25. Following the completion of the sale, the insider directly owned 72,126 shares in the company, valued at approximately $5,394,303.54. This represents a 24.08% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 46,552 shares of company stock worth $3,491,951 over the last ninety days. Insiders own 1.01% of the company's stock.

Docusign declared that its board has approved a share repurchase program on Thursday, June 5th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the company to reacquire up to 6.6% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board believes its stock is undervalued.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.